Gliosis attenuation in experimental autoimmune encephalomyelitis by a combination of dimethyl fumarate and pregabalin

Gliosis attenuation in experimental autoimmune encephalomyelitis by a combination of dimethyl fumarate and pregabalin

Dysregulated microglia and astrocytes have been associated with progressive neurodegeneration in multiple sclerosis (MS), highlighting the need for strategies that additionally target intrinsic inflammation in the central nervous system (CNS). The objective of the present study was to investigate th...

Full description

Bibliographic Details
Main Authors:	Amanda Garcia Hoelz, Danielle Bernardes, Luciana Politti Cartarozzi, Alexandre Leite Rodrigues de Oliveira
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	experimental autoimmune encephalomyelitis (EAE) microglia astrocytes dimethyl fumarate (DMF) pregabalin (PGB)
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2022.921916/full

Similar Items

Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge
by: Hallel C. Paraiso, et al.
Published: (2018-03-01)

The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
by: Federico Manai, et al.
Published: (2022-12-01)

Dimethyl Fumarate Alleviates NLRP3 Inflammasome Activation in Microglia and Sickness Behavior in LPS-Challenged Mice
by: Bora Tastan, et al.
Published: (2021-11-01)

Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise
by: Shilu Deepa Thomas, et al.
Published: (2022-04-01)

Effect of dimethyl fumarate on heme oxygenase-1 expression in experimental allergic encephalomyelitis in rats
by: Kaja Kasarełło, et al.
Published: (2017-12-01)

Pregabalin as a Pain Therapeutic: Beyond Calcium Channels
by: Sascha R. A. Alles, et al.
Published: (2020-04-01)

Astragaloside IV inhibits experimental autoimmune encephalomyelitis by modulating the polarization of both microglia/macrophages and astrocytes
by: Jingwen Yu, et al.
Published: (2023-07-01)

Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection
by: Yoelvis Garcia-Mesa, et al.
Published: (2021-03-01)

ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer’s Disease
by: Luisa Möhle, et al.
Published: (2023-06-01)

The association between Gabapentin or Pregabalin use and the risk of dementia: an analysis of the National Health Insurance Research Database in Taiwan
by: Yu-Hua Huang, et al.
Published: (2023-05-01)

Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
by: Maria Rosito, et al.
Published: (2020-08-01)

Patients monitoring during treatment with Dimethyl fumarate (ORP-23)
by: Ali Yousefi Pour
Published: (2023-01-01)

Dimethyl Fumarate as Potential Treatment for Alzheimer’s Disease: Rationale and Clinical Trial Design
by: Robert Sharkus, et al.
Published: (2023-05-01)

Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease
by: Ting Wang, et al.
Published: (2024-02-01)

Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate Structure
by: Valeria Sorrenti, et al.
Published: (2020-12-01)

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
by: Martina Burlando, et al.
Published: (2021-10-01)

Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation
by: S. K. Vainio, et al.
Published: (2022-02-01)

Effects of dimethyl fumarate on neuroprotection and immunomodulation
by: Albrecht Philipp, et al.
Published: (2012-07-01)

Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
by: Ulaş Ceylan, et al.
Published: (2021-05-01)

The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary Results
by: Thilo Gambichler, et al.
Published: (2023-01-01)

Dimethyl fumarate reduces inflammation in chronic active multiple sclerosis lesions
by: Zinger, Nicole, et al.
Published: (2023)

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
by: Shiri Li, et al.
Published: (2021-01-01)

Transcriptomic Analysis of Fumarate Compounds Identifies Unique Effects of Isosorbide Di-(Methyl Fumarate) on NRF2, NF-kappaB and IRF1 Pathway Genes
by: William R. Swindell, et al.
Published: (2022-04-01)

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
by: Laura Gnesotto, et al.
Published: (2023-03-01)

Dimethyl fumarate for treating Papillon–Lefèvre syndrome
by: Abdullah Al-Omair, MD, et al.
Published: (2023-01-01)

Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023-07-01)

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
by: Stephanie Kourakis, et al.
Published: (2020-10-01)

Gene Expression Analysis of Astrocyte and Microglia Endocannabinoid Signaling during Autoimmune Demyelination
by: Álvaro Moreno-García, et al.
Published: (2020-08-01)

Utilization of dimethyl fumarate and related molecules for treatment of multiple sclerosis, cancer, and other diseases
by: Azzam Maghazachi, et al.
Published: (2016-07-01)

A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles
by: Francisco Javier García-Fernández, et al.
Published: (2021-02-01)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021-05-01)

Effect and mechanism of dimethyl fumarate on septic cardiomyopathy in mice
by: MIN Weixiang, et al.
Published: (2022-11-01)

Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
by: Sarah A. Scuderi, et al.
Published: (2020-07-01)

Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
by: Cara A. Timpani, et al.
Published: (2020-12-01)

Repurposing dimethyl fumarate for gastric ulcer and ulcerative colitis: Evidence of local efficacy without systemic side effect
by: Vishal Patel, et al.
Published: (2022-12-01)

The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
by: Roberto De Masi, et al.
Published: (2021-01-01)

Dimethyl Fumarate Used as an Effective Treatment for Granuloma Annulare Disseminatum: An Immunohistochemical Case Study
by: Max Gabutti, et al.
Published: (2023-08-01)

Genetic Study of Severe Prolonged Lymphopenia in Multiple Sclerosis Patients Treated With Dimethyl Fumarate
by: Dipen Sangurdekar, et al.
Published: (2019-11-01)

Comparison of dimethyl fumarate and interferon outcomes in an MS cohort
by: Neda Sattarnezhad, et al.
Published: (2022-07-01)

USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS
by: V. R. Mkrtchyan, et al.
Published: (2016-12-01)